14 Nov 2025 | 3 Mins Read
Pharma stock surges 11% on 56% YoY profit growth
Flipitmoney
Rubicon Research reported strong Q2FY26 results with 38% revenue growth and 56% profit jump due to better margins, strong demand, and higher operational efficiency. The company, known for complex pharmaceutical formulations, saw revenue and profit growth, positively impacting investors, with its stock surging 11% after releasing its results.